Zymeworks Financials - Benzinga

Zymeworks Inc

ZYMENASDAQ

Trade with Public

Trade with Public

$29.90

-1.15-3.7%

At close: Sep 3, 5:00 PM EST

$29.90

N/A

After Hours: 4:00 PM EST

Overview News Earnings Forecast Events Price TargetsFinancialsSentiment Ownership Compare Options Stock Report

Zymeworks Financials

Zymeworks (ZYME) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
Zymeworks Q2 EPS $(0.62) Misses $(0.41) Estimate, Sales $4.590M Miss $18.011M Estimate

Benzinga Newsdesk

PRO
Zymeworks Q1 EPS $(0.59) Down From $(0.30) YoY, Sales $2.408M Down From $27.110M YoY

Zymeworks (NASDAQ:ZYME) reported quarterly losses of $(0.59) per share. This is a 96.67 percent decrease over losses of $(0.30) per share from the same period last year. The company reported $2.408 million in sales this

Benzinga Newsdesk

Earnings Scheduled For March 2, 2026

Benzinga Insights

Earnings Breakdown: Zymeworks Q4

Benzinga Insights

PRO
Zymeworks Q4 2025 EPS $(0.55) Misses $(0.42) Estimate, Sales $2.515M Miss $13.576M Estimate

Benzinga Newsdesk

A Look Ahead: Zymeworks's Earnings Forecast

Benzinga Insights